Thyroid hormone and cardiovascular disease

被引:131
作者
Gomberg-Maitland, M
Frishman, WH [1 ]
机构
[1] New York Med Coll, Valhalla, NY 10595 USA
[2] Cornell Univ, Med Ctr, New York Hosp, Dept Med, New York, NY 10021 USA
关键词
D O I
10.1016/S0002-8703(98)70081-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thyroid hormone directly affects the heart and peripheral vascular system. The hormone can increase myocardial inotropy and heart rate and dilate peripheral arteries to increase cardiac output. An excessive deficiency of thyroid hormone can cause cardiovascular disease and aggravate many preexisting conditions. In severe systemic illness and after major surgical procedures changes in thyroid function can occur, leading to the "euthyroid sick syndrome." Patients will have normal or decreased levels of T-4, decreased free and total T-3, and usually normal levels of thyroid stimulating hormone. This syndrome may be an adaptive response to systemic illness that usually will revert to normal without hormone supplementation as the illness subsides. Recently, however, many investigators have explored the benefits of thyroid hormone supplementation in those diseases associated with euthyroid sick syndrome. Thyroid hormone's effects on the cardiovascular system make ii an attractive therapy for those patients with impaired hemodynamics and low T-3. Thyroid hormone has also been considered a treatment for patients with congestive heart failure, for patients undergoing cardiopulmonary bypass and heart transplantation, and for patients with hyperlipidemia. At present there is no evidence suggesting a favorable treatment outcome using thyroid hormone supplementation for any systemic condition except in those patients with documented hypothyroidism.
引用
收藏
页码:187 / 196
页数:10
相关论文
共 111 条
[41]   Thyroid hormone abnormalities in heart failure: Possibilities for therapy [J].
Hamilton, MA ;
Stevenson, LW .
THYROID, 1996, 6 (05) :527-529
[42]   ALTERED THYROID-HORMONE METABOLISM IN ADVANCED HEART-FAILURE [J].
HAMILTON, MA ;
STEVENSON, LW ;
LUU, M ;
WALDEN, JA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 16 (01) :91-95
[43]  
HAMILTON MA, 1995, J AM COLL CARDIOL, V25, pA417
[44]   INCREASED MYOCARDIAL BETA-RECEPTORS AND ADRENERGIC RESPONSES IN HYPERTHYROID PIGS [J].
HAMMOND, HK ;
WHITE, FC ;
BUXTON, ILO ;
SALTZSTEIN, P ;
BRUNTON, LL ;
LONGHURST, JC .
AMERICAN JOURNAL OF PHYSIOLOGY, 1987, 252 (02) :H283-H290
[45]   ASSOCIATIONS BETWEEN SEX-HORMONES, THYROID-HORMONES AND LIPOPROTEINS [J].
HELLER, RF ;
MILLER, NE ;
LEWIS, B ;
VERMEULEN, A ;
FAIRNEY, A ;
JAMES, VHT ;
SWAN, AV .
CLINICAL SCIENCE, 1981, 61 (05) :649-651
[46]   CARDIOPULMONARY BYPASS AND THYROID-FUNCTION - A EUTHYROID SICK SYNDROME [J].
HOLLAND, FW ;
BROWN, PS ;
WEINTRAUB, BD ;
CLARK, RE .
ANNALS OF THORACIC SURGERY, 1991, 52 (01) :46-50
[47]   Effect of triiodothyronine administration in experimental myocardial injury [J].
Hsu, RB ;
Huang, TS ;
Chen, YS ;
Chu, SH .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1995, 18 (09) :702-709
[48]   LIPID-LOWERING DRUGS - AN OVERVIEW OF INDICATIONS AND OPTIMUM THERAPEUTIC USE [J].
ILLINGWORTH, DR .
DRUGS, 1987, 33 (03) :259-279
[49]   STIMULATION OF ACTIVE NA+ AND K+-TRANSPORT BY THYROID-HORMONE IN A RAT-LIVER CELL-LINE - ROLE OF ENHANCED NA+ ENTRY [J].
ISMAILBEIGI, F ;
HABER, RS ;
LOEB, JN .
ENDOCRINOLOGY, 1986, 119 (06) :2527-2536
[50]  
JEEVANANDAM V, 1994, J HEART LUNG TRANSPL, V13, P681